Developing innovative botanical therapies.

Selective by design

We leverage the unique properties of plant origins to create innovative APIs that selectively target specific tissues, without affecting unwanted ones — therapies that can be used long-term without imposing risk on the user.

Standardization of proprietary APIs

In a cGMP production facility, Se-cure applies a multi-layer standardization methodology to guarantee batch-to-batch therapeutic consistency.

1. 01
   Raw material standardization

   A proprietary in-house process stabilises botanical raw material from yield to yield, providing API consistency with a clear fingerprint.

2. 02
   In-line controls

   Analytical tools monitor consistency of formulations while in process; bio-chemical tools monitor residuals and microorganisms.

3. 03
   Finished product controls

   Analytical tools define the release criteria of every finished product.